Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8779-8789
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8779
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8779
Clinicopathological features | |
Patients | n = 77 |
Gender | male : female = 38 : 10 |
Age (yr) | mean = 66.6 (44-85) |
Virus infection | HCV : HBV : NBNC = 72 : 4 : 1 |
UICC-TNM classification | I : II : IIIA : IIIB = 41 : 32 : 3 : 1 |
Tumor number | single : multiple : unknown = 48 : 28 : 1 |
Tumor size (cm) | mean = 3.0 (1.0-9.5) |
Portal vein invasion | yes : no : unknown = 7 : 68 : 2 |
Tumor differentiation | well : mod : poor : unknown = 18 : 44 : 13 : 2 |
Number of platelet (× 104) | mean = 13.4 (3.8-28.1) |
Alanine aminotransferase (ALT) (U/L) | mean = 50.9 (16-207) |
Total bilirubin (mg/dL) | mean = 0.9 (0.3-1.9) |
Prothrombin activity (%) | mean = 77.1 (33.0-104.0) |
Indocyanine green R15 (%) | mean = 19.1 (6.0-44.4) |
Alpha-fetoprotein (ng/mL) | mean = 389.6 (1.8-602.6) |
- Citation: Kono H, Fujii H, Furuya S, Hara M, Hirayama K, Akazawa Y, Nakata Y, Tsuchiya M, Hosomura N, Sun C. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma. World J Gastroenterol 2016; 22(39): 8779-8789
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8779.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8779